{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T07:14:32Z","timestamp":1792134872100,"version":"4.4.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,28]],"date-time":"2021-03-28T00:00:00Z","timestamp":1616889600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,28]],"date-time":"2021-03-28T00:00:00Z","timestamp":1616889600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1007\/s11060-021-03741-7","type":"journal-article","created":{"date-parts":[[2021,3,28]],"date-time":"2021-03-28T13:02:20Z","timestamp":1616936540000},"page":"55-64","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Multimodal management of surgery- and radiation-refractory meningiomas: an analysis of the French national tumor board meeting on meningiomas cohort"],"prefix":"10.1007","volume":"153","author":[{"given":"Tuan","family":"Le Van","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Graillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Jacob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elodie","family":"Vauleon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loic","family":"Feuvret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Laure","family":"Boch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Boetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Boone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Bronnimann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Caire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amaury","family":"De Barros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariette","family":"Delaitre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Luisa","family":"Di Stefano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e9lanie","family":"Dore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Ducray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christelle","family":"Dufour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Engelhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denys","family":"Fontaine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastien","family":"Froelich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu","family":"Helleringer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aymeri","family":"Huchet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Joncour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Jouanneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles-Henry","family":"Mallereau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apolline","family":"Monfilliette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Le Fur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilyess","family":"Zemmoura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Chinot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Sanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Kalamarides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugues","family":"Loiseau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8470-9516","authenticated-orcid":false,"given":"Matthieu","family":"Peyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,28]]},"reference":[{"issue":"122","key":"3741_CR1","doi-asserted-by":"publisher","first-page":"iv1","DOI":"10.1093\/neuonc\/noaa200","volume":"22","author":"QT Ostrom","year":"2020","unstructured":"Ostrom QT, Patil N, Cioffi G, Waite K, Kruchko C, Barnholtz-Sloan JS (2020) CBTRUS statistical report primary brain and other central nervous system tumors diagnosed in the United States in 2013\u20132017. Neuro-Oncol 22(122):iv1\u2013iv96","journal-title":"Neuro-Oncol"},{"issue":"5","key":"3741_CR2","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.ijrobp.2007.12.020","volume":"71","author":"D Pasquier","year":"2008","unstructured":"Pasquier D, Bijmolt S, Veninga T, Rezvoy N, Villa S, Krengli M et al (2008) Atypical and malignant meningioma: outcome and prognostic factors in 119 irradiated patients. A multicenter, retrospective study of the Rare Cancer Network. Int J Radiat Oncol Biol Phys. 71(5):1388\u20131393","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"3","key":"3741_CR3","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s11060-009-9934-0","volume":"95","author":"A Durand","year":"2009","unstructured":"Durand A, Labrousse F, Jouvet A, Bauchet L, Kalamarid\u00e8s M, Menei P et al (2009) WHO grade II and III meningiomas: a study of prognostic factors. J Neurooncol 95(3):367\u2013375","journal-title":"J Neurooncol"},{"issue":"5","key":"3741_CR4","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1093\/neuonc\/nou025","volume":"16","author":"G Kaur","year":"2014","unstructured":"Kaur G, Sayegh ET, Larson A, Bloch O, Madden M, Sun MZ et al (2014) Adjuvant radiotherapy for atypical and malignant meningiomas: a systematic review. Neuro-Oncol 16(5):628\u2013636","journal-title":"Neuro-Oncol"},{"issue":"10","key":"3741_CR5","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1586\/ern.11.38","volume":"11","author":"MC Chamberlain","year":"2011","unstructured":"Chamberlain MC, Barnholtz-Sloan JS (2011) Medical treatment of recurrent meningiomas. Expert Rev Neurother 11(10):1425\u20131432","journal-title":"Expert Rev Neurother"},{"issue":"1","key":"3741_CR6","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.neuchi.2014.11.013","volume":"64","author":"S Zouaoui","year":"2018","unstructured":"Zouaoui S, Darlix A, Rigau V, Mathieu-Daud\u00e9 H, Bauchet F, Bessaoud F et al (2018) Descriptive epidemiology of 13,038 newly diagnosed and histologically confirmed meningiomas in France: 2006\u20132010. Neurochirurgie 64(1):15\u201321","journal-title":"Neurochirurgie"},{"issue":"4","key":"3741_CR7","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1093\/neuonc\/nov247","volume":"18","author":"CL Rogers","year":"2016","unstructured":"Rogers CL, Perry A, Pugh S, Vogelbaum MA, Brachman D, McMillan W et al (2016) Pathology concordance levels for meningioma classification and grading in NRG Oncology RTOG Trial 0539. Neuro-Oncol 18(4):565\u2013574","journal-title":"Neuro-Oncol"},{"issue":"5","key":"3741_CR8","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/S1470-2045(17)30155-9","volume":"18","author":"F Sahm","year":"2017","unstructured":"Sahm F, Schrimpf D, Stichel D, Jones DTW, Hielscher T, Schefzyk S et al (2017) DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis. Lancet Oncol 18(5):682\u2013694","journal-title":"Lancet Oncol"},{"issue":"3","key":"3741_CR9","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s11060-018-2912-7","volume":"139","author":"A Biczok","year":"2018","unstructured":"Biczok A, Kraus T, Suchorska B, Terpolilli NA, Thorsteinsdottir J, Giese A et al (2018) TERT promoter mutation is associated with worse prognosis in WHO grade II and III meningiomas. J Neurooncol 139(3):671\u2013678","journal-title":"J Neurooncol"},{"issue":"6","key":"3741_CR10","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1007\/s00401-018-1844-9","volume":"135","author":"LM Katz","year":"2018","unstructured":"Katz LM, Hielscher T, Liechty B, Silverman J, Zagzag D, Sen R et al (2018) Loss of histone H3K27me3 identifies a subset of meningiomas with increased risk of recurrence. Acta Neuropathol (Berl) 135(6):955\u2013963","journal-title":"Acta Neuropathol (Berl)"},{"key":"3741_CR11","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s00401-020-02188-w","volume":"140","author":"P Sievers","year":"2020","unstructured":"Sievers P, Hielscher T, Schrimpf D, Stichel D, Reuss DE, Berghoff AS et al (2020) CDKN2A\/B homozygous deletion is associated with early recurrence in meningiomas. Acta Neuropathol (Berl) 140:409\u2013413","journal-title":"Acta Neuropathol (Berl)"},{"issue":"2","key":"3741_CR12","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nrneurol.2017.168","volume":"14","author":"M Preusser","year":"2018","unstructured":"Preusser M, Brastianos PK, Mawrin C (2018) Advances in meningioma genetics: novel therapeutic opportunities. Nat Rev Neurol 14(2):106\u2013115","journal-title":"Nat Rev Neurol"},{"issue":"5","key":"3741_CR13","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1093\/neuonc\/nov316","volume":"18","author":"M Abedalthagafi","year":"2016","unstructured":"Abedalthagafi M, Bi WL, Aizer AA, Merrill PH, Brewster R, Agarwalla PK et al (2016) Oncogenic PI3K mutations are as common as AKT1 and SMO mutations in meningioma. Neuro-Oncol 18(5):649\u2013655","journal-title":"Neuro-Oncol"},{"issue":"1","key":"3741_CR14","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3171\/2014.7.JNS131644","volume":"122","author":"L Rogers","year":"2015","unstructured":"Rogers L, Barani I, Chamberlain M, Kaley TJ, McDermott M, Raizer J et al (2015) Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review J Neurosurg 122(1):4\u201323","journal-title":"A RANO review J Neurosurg"},{"issue":"8","key":"3741_CR15","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1093\/neuonc\/nox231","volume":"20","author":"M Peyre","year":"2018","unstructured":"Peyre M, Gauchotte G, Giry M, Froehlich S, Pallud J, Graillon T et al (2018) De novo and secondary anaplastic meningiomas a study of clinical and histomolecular prognostic factors. Neuro-Oncol. 20(8):1113\u20131121","journal-title":"Neuro-Oncol."},{"issue":"6","key":"3741_CR16","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1093\/neuonc\/not330","volume":"16","author":"T Kaley","year":"2014","unstructured":"Kaley T, Barani I, Chamberlain M, McDermott M, Panageas K, Raizer J et al (2014) Historical benchmarks for medical therapy trials in surgery- and radiation-refractory meningioma: a RANO review. Neuro-Oncol 16(6):829\u2013840","journal-title":"Neuro-Oncol"},{"issue":"2","key":"3741_CR17","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s11060-011-0741-z","volume":"107","author":"MC Chamberlain","year":"2012","unstructured":"Chamberlain MC (2012) Hydroxyurea for recurrent surgery and radiation refractory high-grade meningioma. J Neurooncol 107(2):315\u2013321","journal-title":"J Neurooncol"},{"issue":"3","key":"3741_CR18","doi-asserted-by":"publisher","first-page":"227","DOI":"10.2217\/cns.13.17","volume":"2","author":"MC Chamberlain","year":"2013","unstructured":"Chamberlain MC (2013) IFN-\u03b1 for recurrent surgery- and radiation-refractory high-grade meningioma: a retrospective case series. CNS Oncol 2(3):227\u2013235","journal-title":"CNS Oncol"},{"issue":"5","key":"3741_CR19","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1093\/neuonc\/nor044","volume":"13","author":"DR Johnson","year":"2011","unstructured":"Johnson DR, Kimmel DW, Burch PA, Cascino TL, Giannini C, Wu W et al (2011) Phase II study of subcutaneous octreotide in adults with recurrent or progressive meningioma and meningeal hemangiopericytoma. Neuro-Oncol 13(5):530\u2013535","journal-title":"Neuro-Oncol"},{"issue":"5","key":"3741_CR20","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1007\/s00280-014-2422-z","volume":"73","author":"M Sim\u00f3","year":"2014","unstructured":"Sim\u00f3 M, Argyriou AA, Maci\u00e0 M, Plans G, Maj\u00f3s C, Vidal N et al (2014) Recurrent high-grade meningioma: a phase II trial with somatostatin analogue therapy. Cancer Chemother Pharmacol 73(5):919\u2013923","journal-title":"Cancer Chemother Pharmacol"},{"issue":"1","key":"3741_CR21","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1093\/neuonc\/noy137","volume":"21","author":"RY Huang","year":"2019","unstructured":"Huang RY, Bi WL, Weller M, Kaley T, Blakeley J, Dunn I et al (2019) Proposed response assessment and endpoints for meningioma clinical trials report from the response assessment in neuro-oncology working group. Neuro-Oncol. 21(1):26\u201336","journal-title":"Neuro-Oncol."},{"issue":"3","key":"3741_CR22","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1158\/1078-0432.CCR-19-2109","volume":"26","author":"T Graillon","year":"2020","unstructured":"Graillon T, Sanson M, Campello C, Idbaih A, Peyre M, Peyri\u00e8re H et al (2020) Everolimus and octreotide for patients with recurrent meningioma: results from the phase II CEVOREM trial. Clin Cancer Res Off J Am Assoc Cancer Res 26(3):552\u2013557","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"issue":"1","key":"3741_CR23","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s11060-012-0886-4","volume":"109","author":"L Nayak","year":"2012","unstructured":"Nayak L, Iwamoto FM, Rudnick JD, Norden AD, Lee EQ, Drappatz J et al (2012) Atypical and anaplastic meningiomas treated with bevacizumab. J Neurooncol 109(1):187\u2013193","journal-title":"J Neurooncol"},{"issue":"2","key":"3741_CR24","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s11060-016-2172-3","volume":"129","author":"KC Shih","year":"2016","unstructured":"Shih KC, Chowdhary S, Rosenblatt P, Weir AB, Shepard GC, Williams JT et al (2016) A phase II trial of bevacizumab and everolimus as treatment for patients with refractory, progressive intracranial meningioma. J Neurooncol 129(2):281\u2013288","journal-title":"J Neurooncol"},{"issue":"1","key":"3741_CR25","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s11060-012-0861-0","volume":"109","author":"E Lou","year":"2012","unstructured":"Lou E, Sumrall AL, Turner S, Peters KB, Desjardins A, Vredenburgh JJ et al (2012) Bevacizumab therapy for adults with recurrent\/progressive meningioma: a retrospective series. J Neurooncol 109(1):63\u201370","journal-title":"J Neurooncol"},{"key":"3741_CR26","doi-asserted-by":"publisher","first-page":"133","DOI":"10.4103\/sni.sni_264_17","volume":"9","author":"AJ Franke","year":"2018","unstructured":"Franke AJ, Skelton WP, Woody LE, Bregy A, Shah AH, Vakharia K et al (2018) Role of bevacizumab for treatment-refractory meningiomas: A systematic analysis and literature review. Surg Neurol Int 9:133","journal-title":"Surg Neurol Int"},{"issue":"9","key":"3741_CR27","doi-asserted-by":"publisher","first-page":"e383","DOI":"10.1016\/S1470-2045(16)30321-7","volume":"17","author":"R Goldbrunner","year":"2016","unstructured":"Goldbrunner R, Minniti G, Preusser M, Jenkinson MD, Sallabanda K, Houdart E et al (2016) EANO guidelines for the diagnosis and treatment of meningiomas. Lancet Oncol 17(9):e383-391","journal-title":"Lancet Oncol"},{"key":"3741_CR28","doi-asserted-by":"crossref","unstructured":"Jenkinson MD, Javadpour M, Haylock BJ, Young B, Gillard H, Vinten J, et al. The ROAM\/EORTC-1308 trial: Radiation versus Observation following surgical resection of Atypical Meningioma: study protocol for a randomised controlled trial. Trials [Internet]. 2015 Nov 14 [cited 2020 Jul 16];16. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4650615\/","DOI":"10.1186\/s13063-015-1040-3"},{"issue":"1","key":"3741_CR29","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.ijrobp.2018.05.011","volume":"102","author":"AJ Lin","year":"2018","unstructured":"Lin AJ, Hui C, Dahiya S, Lu H-C, Kim AH, Campian JL et al (2018) Radiologic response and disease control of recurrent intracranial meningiomas treated with reirradiation. Int J Radiat Oncol Biol Phys. 102(1):194\u2013203","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"1","key":"3741_CR30","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s13014-018-1026-x","volume":"13","author":"RA El Shafie","year":"2018","unstructured":"El Shafie RA, Czech M, Kessel KA, Habermehl D, Weber D, Rieken S et al (2018) Evaluation of particle radiotherapy for the re-irradiation of recurrent intracranial meningioma. Radiat Oncol Lond Engl 13(1):86","journal-title":"Radiat Oncol Lond Engl"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-021-03741-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-021-03741-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-021-03741-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T06:04:55Z","timestamp":1621317895000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-021-03741-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,28]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["3741"],"URL":"https:\/\/doi.org\/10.1007\/s11060-021-03741-7","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,28]]},"assertion":[{"value":"12 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflict of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The Ethics in Research Committee of the French National College of Neurosurgeons approved this retrospective chart review (NOIRB00011687).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate and for publication"}}]}}